Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07269769 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Clinical Trial Evaluating the Efficacy and Safety of Sanhuang Jingshiming Pills in the Treatment of nAMD

StatusNot Yet Recruiting
PhasePhase 3
Started2026-04-30
View on ClinicalTrials.gov ↗

Amendment history

2026-04-02
Study Status v2
Start date2026-01-01→2026-04-30
2025-12-07
Study Status, Outcome Measures v1
Secondary endpointsdetails revised at 3 of 12 entries
2025-11-25
Original filing
The purpose of the TSL-TCM-SHJSMW-Ⅲ study is to study the efficacy and safety of Sanhuang Jingshiming Pills in subjects with Neovascular Age-Related Macular Degeneration.
Trial Details
NCT Number NCT07269769
Lead Sponsor Tasly Pharmaceutical Group Co., Ltd
Conditions AMD
Enrollment 450 participants
Start Date 2026-04-30
Primary Completion 2031-12-31 (estimated)
Study Completion 2031-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-08